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Background
Follow-up of surgically treated colorectal cancer patients is
not supported by objectively certain data. Despite the thou-
sands of investigations reported in the literature, only six
randomized prospective studies and two meta-analysis of
randomized studies provide data suggesting clear conclu-
sions until today. The main goal of colorectal follow-up is
to improve patient survival by early diagnosis of recurrence
during the asymptomatic stage when radical surgical treat-
ment is more viable [1]. However the reduction of global
mortality from colorectal cancer achieved by follow-up,
radical second-surgery and therefore new and definite
patient recovery calculated in our patients in follow-up on
5 years disease free interval was only 2.6 % according to
the findings of other authors [2,3]. In our recent study car-
ried out on a group of 280 patients in our follow-up the
average age was 69.5 demonstrating that the age must be
carefully considered in order to establish the follow-up tim-
ing and modality and to calculate the cost-benefit ratio. In
our experience the far from brilliant results obtained led us
to change our follow-up in 2006 and make it less intensive,
tailoring it to the stage of the disease, the reliability of the
diagnostic methods, times of recurrences and no less
important, the age of patients. In the aged obviously the
surgical and/or adjuvant and neoadjuvant treatments are to
be considered with caution and local and general controin-
dications to every type of therapy carefully evaluated. The
age is a fundamental part of ASA, POSSUM and PST and
could condition the therapeutical strategies. On the other
hand many reports confirm the possibility of performing
safe operation for liver and lung metastases or local recur-
rences in the elderly without a statistical higher rate of
morbidity and mortality compounding with younger adults.
Lastly, in our policy we have considered the agreement of
elderly patients to modality and timing of follow-up on the
basis of a study carried out with the collaboration of a psy-
chological team. On the basis of those experiences we also
believe that in some patients and circumstances a major
involvement of family doctors substituting the institutional
follow-up staff is necessary.
Conclusions
Thus, even if the follow-up is lacking in evidence of
benefits it remains a “good practise”: however in the
elderly we have to reflect, as does Smith in 1998, “is it
really better to know one has incurable metastases
earlier than to believe one is well when one feels well?”
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